[Other] A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Dr.M Post time 2024-5-7 04:18:03 | Show all posts |Read mode
Reward20points

journal£ºNew England Journal of Medicine

Authors£ºStephen A. Harrison; Pierre Bedossa; Cynthia D. Guy; Jorn M. Schattenberg; Rohit Loomba; Rebecca Taub; Dominic Labriola; Sam E. Moussa; Guy W. Neff; Mary E. Rinella; Quentin M. Anstee; Manal F. Abdelmalek; Zobair Younossi; Seth J. Baum; Sven Francque; Michael R. Charlton; Philip N. Newsome; Nicolas Lanthier; Ingolf Schiefke; Alessandra Mangia; Juan M. Peric¨¤s; Rashmee Patil; Arun J. Sanyal; Mazen Noureddin; Meena B. Bansal; Naim Alkhouri; Laurent Castera; Madhavi Rudraraju; Vlad Ratziu

Published date£º2024-2-8

DOI£º10.1056/nejmoa2309000

PDF link£ºhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2309000

Article link£ºhttp://dx.doi.org/10.1056/nejmoa2309000

Article Source£ºMassachusetts Medical Society¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
rodsbraga Post time 2024-5-7 04:18:04 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

rodsbraga Post time 2024-5-7 06:06:58 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    190

Latest Reply

Return to the list